Arthur Fratamico

Arthur Fratamico

Directeur/Bestuurslid bij SUN BIOPHARMA INC
61 jaar
Health Technology
Consumer Services

Profiel

Arthur J.
Fratamico
is currently an Independent Director at Panbela Therapeutics, Inc., a position held since 2019.
Formerly, Mr. Fratamico was President & Chief Executive Officer at Radiant Biotherapeutics, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, Principal at Hoechst Marion Roussel, Inc., Chief Business Officer at Trevena, Inc., and Chief Business Officer at Galera Therapeutics, Inc. Education includes an MBA from Drexel University and undergraduate studies at Philadelphia College of Pharmacy.

Actieve functies van Arthur Fratamico

BedrijvenFunctieBegin
SUN BIOPHARMA INC Directeur/Bestuurslid 16-12-2019

Eerdere bekende functies van Arthur Fratamico

BedrijvenFunctieEinde
VITAE PHARMACEUTICALS INC Corporate Officer/Principal 25-12-2016
FLEXION THERAPEUTICS, INC. Corporate Officer/Principal 01-01-2014
Algemeen Directeur -
GALERA T COM USD0. Corporate Officer/Principal -
TREVENA, INC. Corporate Officer/Principal -
Ervaring van Arthur Fratamico in detail bekijken

Opleiding van Arthur Fratamico

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

37

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Arthur Fratamico